Operator of a pharmaceutical company for the treatment of Alzheimer's disease. The company offers a medicinal treatment for patients with Alzheimer's disease to slow down or halt the damage to the brain's nerve cells. The company has developed proprietary GSK-3 inhibitors as drug candidates.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 03-Feb-2016 | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Hagit Eldar-Finkelman Ph.D | Founder |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Brainnovations | Accelerator/Incubator | 000 0000 | 000000 0 |